What Is Neuphoria Therapeutics Inc. (NEUP) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Neuphoria Therapeutics Inc.. Trading at $3.52 against an estimated intrinsic value of $5.41, 8 of 10 active models flag meaningful upside of +53.6% on average. The most optimistic model, Regime Cross, places fair value at $10.06 (+185.8%), while ML-RIV — the most conservative — estimates $2.38 (-32.4%). This +218.3% gap reflects genuine analytical uncertainty about Neuphoria Therapeutics Inc.'s intrinsic worth.
What Do the Models Say About NEUP?
10 of 13 models are currently active for NEUP. Of these, 8 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates NEUP's intrinsic value at $3.09, implying -12.3% downside from the current price. See which stocks rank higher →
How Does NEUP Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, NEUP ranks #198 by Quality of Company score. CirclFi's QOC score of 5.1/10 evaluates 32 fundamental signals. A score of 5.1 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to pharmaceutical industry businesses. For Neuphoria Therapeutics Inc., metrics like FDA approval probability provide important context that general-purpose valuation models may underweight.
Is NEUP a Value Trap?
CirclFi's Value Trap algorithm assigns NEUP a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for Neuphoria Therapeutics Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Neuphoria Therapeutics Inc. scores 5.1 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +218.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every NEUP valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across NEUP's 10 active models, average confidence is 29%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad